Literature DB >> 7666358

[Hypoglycemic activity and mechanisms of extracts from mulberry leaves (folium mori) and cortex mori radicis in streptozotocin-induced diabetic mice].

F Chen1, N Nakashima, I Kimura, M Kimura.   

Abstract

Averaged blood glucose levels were 400 mg/dl in nonfasted mice, and 250 mg/dl in fasted mice in 4 weeks after injection with streptozotocin (STZ, 150 mg/kg, i.v.). These mice were used for experiments. Hypoglycemic effects of hot water extracts (W) from Folium Mori (Mulberry leaves, Morus alba L., China and Japan) or Cortex Mori Radicis (Morus alba L., China) were observed in fasted and nonfasted STZ-induced diabetic mice at a single dose of 200 mg/kg (i.p.). The W from Folium Mori exhibited most potent hypoglycemic effects. The most potent fractions of Folium Mori and Cortex Mori Radicis were ethanol-insoluble extracts (A2). These A2 fractions demonstrated a fall in blood glucose levels of 24.6 +/- 6.0% and 60.5 +/- 9.1% at nonfasted STZ-mice, and 81.4 +/- 7.9% and 77.3 +/- 5.8% at fasted STZ-mice, respectively. The increase in glucose uptake was a mechanism of hypoglycemic actions by W and A2 of Folium Mori.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666358     DOI: 10.1248/yakushi1947.115.6_476

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  17 in total

Review 1.  A Critical Review on Role of Available Synthetic Drugs and Phytochemicals in Insulin Resistance Treatment by Targeting PTP1B.

Authors:  Prangya Rath; Anuj Ranjan; Abhishek Chauhan; Naval Kumar Verma; Atul Bhargava; Ram Prasad; Tanu Jindal
Journal:  Appl Biochem Biotechnol       Date:  2022-07-11       Impact factor: 3.094

2.  Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves.

Authors:  B Andallu; A V Vinay Kumar; N Ch Varadacharyulu
Journal:  Int J Diabetes Dev Ctries       Date:  2009-07

3.  Evaluation of hypoglycemic effect of Morus alba in an animal model.

Authors:  Jamshid Mohammadi; Prakash R Naik
Journal:  Indian J Pharmacol       Date:  2008-01       Impact factor: 1.200

4.  Hypolipidemic and hypoglycemic effects of Orostachys japonicus A. Berger extracts in streptozotocin-induced diabetic rats.

Authors:  Soo Jung Lee; Gui Fang Zhang; Nak Ju Sung
Journal:  Nutr Res Pract       Date:  2011-08-31       Impact factor: 1.926

5.  Induction of Biologically Active Flavonoids in Cell Cultures of Morus nigra and Testing their Hypoglycemic Efficacy.

Authors:  Ahmed M A Abd El-Mawla; Khaled M Mohamed; Ashraf M Mostafa
Journal:  Sci Pharm       Date:  2011-10-03

6.  Kuwanon V inhibits proliferation, promotes cell survival and increases neurogenesis of neural stem cells.

Authors:  Sun-Young Kong; Min-Hye Park; Mina Lee; Jae-Ouk Kim; Ha-Rim Lee; Byung Woo Han; Clive N Svendsen; Sang Hyun Sung; Hyun-Jung Kim
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

7.  Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats.

Authors:  Attila Hunyadi; Ana Martins; Tusty-Jiuan Hsieh; Adrienn Seres; István Zupkó
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

8.  Fatty Acid Composition of Adipose Tissues in Obese Mice and SD Rats Fed with Isaria sinclairii Powder.

Authors:  Mi Young Ahn; Yun Jung Seo; Sang Deok Ji; Jea Woong Han; Jae Sam Hwang; Eun Young Yun
Journal:  Toxicol Res       Date:  2010-09

9.  A Comparison of Food-grade Folium mori ( Sāng Yè) Extract and 1-Deoxynojirimycin for Glycemic Control and Renal Function in Streptozotocin-induced Diabetic Rats.

Authors:  Shiang-Suo Huang; Yi-Hui Yan; Chien-Hui Ko; Ke-Ming Chen; Shih-Chieh Lee; Cheng-Tzu Liu
Journal:  J Tradit Complement Med       Date:  2014-07

10.  Randomized, Double-Blinded, Double-Dummy, Active-Controlled, and Multiple-Dose Clinical Study Comparing the Efficacy and Safety of Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet and Acarbose in Individuals with Type 2 Diabetes Mellitus.

Authors:  Mengyi Li; Xuemin Huang; Hui Ye; Yao Chen; Jing Yu; Jinxia Yang; Xuezhi Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.